<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD12310000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P62942</UniProt_ID>
  <Seq_Length>108</Seq_Length>
  <Molecule_Weight>11951</Molecule_Weight>
  <KEGG_ID>hsa:2280</KEGG_ID>
  <Orthology_ID>K09568</Orthology_ID>
  <EBI_ID>EBI-1027571</EBI_ID>
  <Function_Summary>Keeps in an inactive conformation TGFBR1, the TGF-beta type I serine/threonine kinase receptor, preventing TGF-beta receptor activation in absence of ligand. Recruites SMAD7 to ACVR1B which prevents the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. May modulate the RYR1 calcium channel activity. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.</Function_Summary>
  <Catalytic_Mechanism>Peptidylproline (omega=180) = peptidylproline (omega=0).</Catalytic_Mechanism>
  <Pfam_ID>PF00254:FKBP_C</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>3</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Calstabin-1</Alias>
      <Alias>FK506-binding protein 1A</Alias>
      <Alias>Rotamase</Alias>
      <Alias>12 kDa FKBP</Alias>
      <Alias>Immunophilin FKBP12</Alias>
      <Alias>FKBP-1A</Alias>
      <Alias>FKBP-12</Alias>
      <Alias>12 kDa FK506-binding protein</Alias>
      <Alias>PPIase FKBP1A</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.</Detail>
      <Keyword>Type I transforming growth factor beta receptor binding</Keyword>
      <Ontology_ID>GO:0034713</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.</Detail>
      <Keyword>Activin binding</Keyword>
      <Ontology_ID>GO:0048185</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5.</Detail>
      <Keyword>Isomerase activity</Keyword>
      <Ontology_ID>GO:0016853</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the transforming growth factor beta receptor.</Detail>
      <Keyword>Transforming growth factor beta receptor binding</Keyword>
      <Ontology_ID>GO:0005160</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a macrolide, any of a large group of structurally related antibiotics produced by Streptomyces species.</Detail>
      <Keyword>Macrolide binding</Keyword>
      <Ontology_ID>GO:0005527</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.</Detail>
      <Keyword>Signal transducer activity</Keyword>
      <Ontology_ID>GO:0004871</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the immunosuppressant FK506.</Detail>
      <Keyword>FK506 binding</Keyword>
      <Ontology_ID>GO:0005528</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: peptidyl-proline (omega=180) = peptidyl-proline (omega=0).</Detail>
      <Keyword>Peptidyl-prolyl cis-trans isomerase activity</Keyword>
      <Ontology_ID>GO:0003755</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a SMAD signaling protein.</Detail>
      <Keyword>SMAD binding</Keyword>
      <Ontology_ID>GO:0046332</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.</Detail>
      <Keyword>Ion channel binding</Keyword>
      <Ontology_ID>GO:0044325</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Positive regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043123</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of fibrils, extracellular matrix material consisting of polysaccharides and protein.</Detail>
      <Keyword>Fibril organization</Keyword>
      <Ontology_ID>GO:0043206</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which calcium ions sequestered in the endoplasmic reticulum or mitochondria are released into the cytosolic compartment.</Detail>
      <Keyword>Release of sequestered calcium ion into cytosol</Keyword>
      <Ontology_ID>GO:0051209</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a transforming growth factor beta receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Transforming growth factor beta receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007179</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of assisting in the folding of a nascent peptide chain into its correct tertiary structure.</Detail>
      <Keyword>'de novo' protein folding</Keyword>
      <Ontology_ID>GO:0006458</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Calcium ion transmembrane transport</Keyword>
      <Ontology_ID>GO:0070588</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.</Detail>
      <Keyword>Heart morphogenesis</Keyword>
      <Ontology_ID>GO:0003007</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.</Detail>
      <Keyword>Protein folding</Keyword>
      <Ontology_ID>GO:0006457</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.</Detail>
      <Keyword>Regulation of immune response</Keyword>
      <Ontology_ID>GO:0050776</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of protein binding.</Detail>
      <Keyword>Positive regulation of protein binding</Keyword>
      <Ontology_ID>GO:0032092</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.</Detail>
      <Keyword>Negative regulation of protein phosphorylation</Keyword>
      <Ontology_ID>GO:0001933</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The expansion of a T cell population by cell division. Follows T cell activation.</Detail>
      <Keyword>T cell proliferation</Keyword>
      <Ontology_ID>GO:0042098</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that results in the attainment of the full functional capacity of a protein.</Detail>
      <Keyword>Protein maturation by protein folding</Keyword>
      <Ontology_ID>GO:0022417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone.</Detail>
      <Keyword>Chaperone-mediated protein folding</Keyword>
      <Ontology_ID>GO:0061077</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of creating a trabecula in the heart. A trabecula is a tissue element in the form of a small beam, strut or rod.</Detail>
      <Keyword>Heart trabecula formation</Keyword>
      <Ontology_ID>GO:0060347</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.</Detail>
      <Keyword>Ventricular cardiac muscle tissue morphogenesis</Keyword>
      <Ontology_ID>GO:0055010</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.</Detail>
      <Keyword>T cell activation</Keyword>
      <Ontology_ID>GO:0042110</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones.</Detail>
      <Keyword>Protein refolding</Keyword>
      <Ontology_ID>GO:0042026</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.</Detail>
      <Keyword>Regulation of protein localization</Keyword>
      <Ontology_ID>GO:0032880</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The modification of a protein by cis-trans isomerization of a proline residue.</Detail>
      <Keyword>Protein peptidyl-prolyl isomerization</Keyword>
      <Ontology_ID>GO:0000413</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops or reduces the activity of the enzyme protein phosphatase type 2B.</Detail>
      <Keyword>Negative regulation of protein phosphatase type 2B activity</Keyword>
      <Ontology_ID>GO:0032513</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which force is generated within muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis.</Detail>
      <Keyword>Muscle contraction</Keyword>
      <Ontology_ID>GO:0006936</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of a cytokine or chemokine binding to a cell surface receptor.</Detail>
      <Keyword>Cytokine-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0019221</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them.</Detail>
      <Keyword>Response to caffeine</Keyword>
      <Ontology_ID>GO:0031000</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the activity of any activin receptor signaling pathway.</Detail>
      <Keyword>Regulation of activin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0032925</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.</Detail>
      <Keyword>Regulation of ryanodine-sensitive calcium-release channel activity</Keyword>
      <Ontology_ID>GO:0060314</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.</Detail>
      <Keyword>Positive regulation of protein ubiquitination</Keyword>
      <Ontology_ID>GO:0031398</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.</Detail>
      <Keyword>Response to iron ion</Keyword>
      <Ontology_ID>GO:0010039</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.</Detail>
      <Keyword>SMAD protein complex assembly</Keyword>
      <Ontology_ID>GO:0007183</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>53</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>53</Position>
      <PTM_Type>N6-succinyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular vesicular exosome</CellLocal>
      <Ontology_ID>GO:0070062</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Axon terminus</CellLocal>
      <Ontology_ID>GO:0043679</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Sarcoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0033017</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Z disc</CellLocal>
      <Ontology_ID>GO:0030018</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Terminal cisterna</CellLocal>
      <Ontology_ID>GO:0014802</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0005789</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>FKBP1A</Gene_Name>
    <Gene_Alias>FKBP1; FKBP12</Gene_Alias>
    <Gene_ID>2280</Gene_ID>
    <Genbank_ACCN>NM_000801</Genbank_ACCN>
    <Protein_ACCN>NP_000792</Protein_ACCN>
    <HGNC_ID>3711</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2280</Gene_URL>
    <UCSC_ID>uc002wey.3</UCSC_ID>
    <EMBL_ID>ENSG00000088832</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P36896</Uniprot_ID>
      <Gene_Name>ACVR1B</Gene_Name>
      <EBI_ID>EBI-1384128</EBI_ID>
      <PPI_EBI_URL>EBI-1027571,EBI-1384128</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P42345</Uniprot_ID>
      <Gene_Name>MTOR</Gene_Name>
      <EBI_ID>EBI-359260</EBI_ID>
      <PPI_EBI_URL>EBI-1027571,EBI-359260</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O15105</Uniprot_ID>
      <Gene_Name>SMAD7</Gene_Name>
      <EBI_ID>EBI-3861591</EBI_ID>
      <PPI_EBI_URL>EBI-1027571,EBI-3861591</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P36897</Uniprot_ID>
      <Gene_Name>TGFBR1</Gene_Name>
      <EBI_ID>EBI-1027557</EBI_ID>
      <PPI_EBI_URL>EBI-1027571,EBI-1027557</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Wildtype FK506-binding protein complexed with Rapamycin</PDB_Title>
      <PDB_ID>2DG3</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DG3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Energetic and structural analysis of the role of tryptophan 59 in FKBP12</PubMed_Title>
      <Author>Fulton, K.F., et al.</Author>
      <Journal>Biochemistry(2003)42:2364-2372</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12600203?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of E60A mutant of FKBP12</PDB_Title>
      <PDB_ID>2PPO</PDB_ID>
      <Resolution>1.29</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PPO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural coupling between FKBP12 and buried water.</PubMed_Title>
      <Author>Szep, S., et al.</Author>
      <Journal>Proteins(2009)74:603-611</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18704951?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK-506-BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818</PDB_Title>
      <PDB_ID>2FKE</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FKE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818.</PubMed_Title>
      <Author>Becker, J.W., et al.</Author>
      <Journal>J.Biol.Chem.(1993)268:11335-11339</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7684380?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK-506 BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818</PDB_Title>
      <PDB_ID>1FKD</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818.</PubMed_Title>
      <Author>Becker, J.W., et al.</Author>
      <Journal>J.Biol.Chem.(1993)268:11335-11339</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7684380?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis of conformational transitions in the active site and 80 s loop in the FK506 binding protein FKBP12</PDB_Title>
      <PDB_ID>4N19</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4N19</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12.</PubMed_Title>
      <Author>Mustafi, S.M., et al.</Author>
      <Journal>Biochem.J.(2014)458:525-536</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24405377?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12</PDB_Title>
      <PDB_ID>1FKH</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>FKBP COMPLEXED WITH METHYL METHYLSULFINYLMETHYL SULFIDE (DSS)</PDB_Title>
      <PDB_ID>1D7I</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D7I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.</PubMed_Title>
      <Author>Burkhard, P., et al.</Author>
      <Journal>J.Mol.Biol.(2000)295:953-962</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10656803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 and dorsomorphin</PDB_Title>
      <PDB_ID>3H9R</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H9R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva.</PubMed_Title>
      <Author>Chaikuad, A., et al.</Author>
      <Journal>J.Biol.Chem.(2012)287:36990-36998</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22977237?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITH IMMUNOSUPPRESSANT FK506</PDB_Title>
      <PDB_ID>1BKF</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BKF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conformation of Fk506 in X-Ray Structures of its Complexes with Human Recombinant Fkbp12 Mutants</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX</PDB_Title>
      <PDB_ID>1FKJ</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin.</PubMed_Title>
      <Author>Wilson, K.P., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1995)51:511-521</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15299838?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506 BINDING PROTEIN COMPLEXED WITH FKB-001</PDB_Title>
      <PDB_ID>1J4R</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J4R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies.</PubMed_Title>
      <Author>Dubowchik, G.M., et al.</Author>
      <Journal>Org.Lett.(2001)3:3987-3990</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11735566?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP</PDB_Title>
      <PDB_ID>1NSG</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NSG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12310002</ASD_Ligand>
      <PubMed_Title>Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.</PubMed_Title>
      <Author>Liang, J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1999)55:736-744</Journal>
      <PubMed_ID>10089303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of E60Q mutant of FKBP12</PDB_Title>
      <PDB_ID>2PPP</PDB_ID>
      <Resolution>0.94</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PPP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural coupling between FKBP12 and buried water.</PubMed_Title>
      <Author>Szep, S., et al.</Author>
      <Journal>Proteins(2009)74:603-611</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18704951?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of FKBP12</PDB_Title>
      <PDB_ID>2PPN</PDB_ID>
      <Resolution>0.92</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PPN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural coupling between FKBP12 and buried water.</PubMed_Title>
      <Author>Szep, S., et al.</Author>
      <Journal>Proteins(2009)74:603-611</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18704951?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>crystal structure analysis of the FKBP12 complexed with 000308 small molecule</PDB_Title>
      <PDB_ID>1J4I</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J4I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design and structure-based study of new potential FKBP12 inhibitors</PubMed_Title>
      <Author>Sun, F., et al.</Author>
      <Journal>Biophys.J.(2003)85:3194-3201</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14581219?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587</PDB_Title>
      <PDB_ID>1QPL</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QPL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein.</PubMed_Title>
      <Author>Becker, J.W., et al.</Author>
      <Journal>J.Med.Chem.(1999)42:2798-2804</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10425089?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with FK506</PDB_Title>
      <PDB_ID>4ODR</PDB_ID>
      <Resolution>1.93</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4ODR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with FK506</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with S3 peptide</PDB_Title>
      <PDB_ID>4ODQ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4ODQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with S3 peptide</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP</PDB_Title>
      <PDB_ID>4FAP</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FAP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12310004</ASD_Ligand>
      <PubMed_Title>Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.</PubMed_Title>
      <Author>Liang, J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1999)55:736-744</Journal>
      <PubMed_ID>10089303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12</PDB_Title>
      <PDB_ID>1B6C</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1B6C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.</PubMed_Title>
      <Author>Huse, M., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1999)96:425-436</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10025408?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with S2-W23A peptide</PDB_Title>
      <PDB_ID>4ODP</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4ODP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of SlyD delta-IF from Thermus thermophilus in complex with S2-W23A peptide</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>crystal structure analysis of the FKBP12 complexed with 000107 small molecule</PDB_Title>
      <PDB_ID>1J4H</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J4H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design and structure-based study of new potential FKBP12 inhibitors</PubMed_Title>
      <Author>Sun, F., et al.</Author>
      <Journal>Biophys.J.(2003)85:3194-3201</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14581219?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND</PDB_Title>
      <PDB_ID>1BL4</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BL4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity.</PubMed_Title>
      <Author>Clackson, T., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1998)95:10437-10442</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9724721?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTING WITH HUMA</PDB_Title>
      <PDB_ID>2FAP</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FAP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12310002</ASD_Ligand>
      <PubMed_Title>Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.</PubMed_Title>
      <Author>Liang, J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1999)55:736-744</Journal>
      <PubMed_ID>10089303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ATOMIC STRUCTURE OF FKBP-FK506, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX</PDB_Title>
      <PDB_ID>1FKF</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.</PubMed_Title>
      <Author>Van Duyne, G.D., et al.</Author>
      <Journal>Science(1991)252:839-842</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1709302?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506-binding protein mutant WF59 complexed with Rapamycin</PDB_Title>
      <PDB_ID>2DG4</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DG4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Energetic and structural analysis of the role of tryptophan 59 in FKBP12</PubMed_Title>
      <Author>Fulton, K.F., et al.</Author>
      <Journal>Biochemistry(2003)42:2364-2372</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12600203?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FKBP12-FK1012 COMPLEX</PDB_Title>
      <PDB_ID>1A7X</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A7X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Chemical inducers of dimerization: the atomic structure of FKBP12-FK1012A-FKBP12.</PubMed_Title>
      <Author>Schultz, L.W., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(1998)8:1-6</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9871618?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FKBP COMPLEXED WITH DMSO</PDB_Title>
      <PDB_ID>1D7H</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D7H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.</PubMed_Title>
      <Author>Burkhard, P., et al.</Author>
      <Journal>J.Mol.Biol.(2000)295:953-962</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10656803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189</PDB_Title>
      <PDB_ID>3MDY</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MDY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX</PDB_Title>
      <PDB_ID>1FKB</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Atomic Structure of the Rapamycin Human Immunophilin Fkbp-12 Complex</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Analyzing the visible conformational substates of the FK506 binding protein FKBP12</PDB_Title>
      <PDB_ID>4IPX</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4IPX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Analysing the visible conformational substates of the FK506-binding protein FKBP12.</PubMed_Title>
      <Author>Mustafi, S.M., et al.</Author>
      <Journal>Biochem.J.(2013)453:371-380</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23688288?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-709,858</PDB_Title>
      <PDB_ID>1QPF</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QPF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein.</PubMed_Title>
      <Author>Becker, J.W., et al.</Author>
      <Journal>J.Med.Chem.(1999)42:2798-2804</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10425089?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP</PDB_Title>
      <PDB_ID>3FAP</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FAP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12310004</ASD_Ligand>
      <PubMed_Title>Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.</PubMed_Title>
      <Author>Liang, J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1999)55:736-744</Journal>
      <PubMed_ID>10089303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP</PDB_Title>
      <PDB_ID>1FAP</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FAP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12310001</ASD_Ligand>
      <PubMed_Title>Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.</PubMed_Title>
      <Author>Choi, J., et al.</Author>
      <Journal>Science(1996)273:239-242</Journal>
      <PubMed_ID>8662507</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FKBP COMPLEXED WITH 4-HYDROXY-2-BUTANONE</PDB_Title>
      <PDB_ID>1D7J</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D7J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.</PubMed_Title>
      <Author>Burkhard, P., et al.</Author>
      <Journal>J.Mol.Biol.(2000)295:953-962</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10656803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12</PDB_Title>
      <PDB_ID>1FKI</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin?</PDB_Title>
      <PDB_ID>4DH0</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DH0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin?</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>FK506-binding protein mutant WL59 complexed with Rapamycin</PDB_Title>
      <PDB_ID>2DG9</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DG9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Energetic and structural analysis of the role of tryptophan 59 in FKBP12</PubMed_Title>
      <Author>Fulton, K.F., et al.</Author>
      <Journal>Biochemistry(2003)42:2364-2372</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12600203?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FK506 BINDING PROTEIN MUTANT, HOMODIMERIC COMPLEX</PDB_Title>
      <PDB_ID>1EYM</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EYM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A ligand-reversible dimerization system for controlling protein-protein interactions.</PubMed_Title>
      <Author>Rollins, C.T., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2000)97:7096-7101</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10852943?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NATIVE FKBP</PDB_Title>
      <PDB_ID>1D6O</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D6O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.</PubMed_Title>
      <Author>Burkhard, P., et al.</Author>
      <Journal>J.Mol.Biol.(2000)295:953-962</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10656803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12</PDB_Title>
      <PDB_ID>1FKG</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FKG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12.</PubMed_Title>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ha.b.b.b.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1a7x</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <PDB_ID>1FAP;1NSG;2FAP;3FAP;4FAP</PDB_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>5.2.1.8</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC5/2/1/8.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD12310001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD12310002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD12310004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>